Publication | Open Access
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF<i>V600E</i>-Mutant<i>KRAS</i>Wild-Type Metastatic Colorectal Cancer
46
Citations
25
References
2023
Year
ClinicalTrials.gov, NCT02278133.
| Year | Citations | |
|---|---|---|
Page 1
Page 1